start here
Sign up for support and helpful information about Rezdiffra.
*Indicates a required field.
The first and only FDA-approved once-daily treatment, along with diet and exercise, for adults with NASH with liver scarring.
*Moderate to advanced liver scarring (fibrosis).
NASH is nonalcoholic steatohepatitis.
Ask your liver specialist if
Rezdiffra is right for you.
Eligible, commercially insured patients may pay as little as $10 with the Rezdiffra Copay Savings Card.†
Not an actual card.
Get the Copay Savings CardEligible, commercially insured patients may pay as little as $10 with the Rezdiffra Copay Savings Card.†
Get the Copay Savings Card†Eligibility rules apply. Offer not valid for patients enrolled in Medicare, Medicaid, or other federal or state healthcare programs. For program terms, conditions, and eligibility criteria, visit copay.rezdiffra.com.
start here
*Indicates a required field.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Rezdiffra may cause serious side effects, including:
These are not all the possible side effects of Rezdiffra. For more information, ask your healthcare provider or pharmacist.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Madrigal Pharmaceuticals, Inc. at 1-800-905-0324.
Rezdiffra is a prescribed medicine used along with diet and exercise to treat adults with nonalcoholic steatohepatitis (NASH) with moderate to advanced liver scarring (fibrosis), but not with cirrhosis of the liver.
It is not known if Rezdiffra is safe and effective in children (under 18 years old).
This indication is approved based on improvement of NASH and liver scarring (fibrosis). There are ongoing studies to confirm the clinical benefit of Rezdiffra.
Please see the full Prescribing Information, including Patient Information, for Rezdiffra.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Rezdiffra may cause serious side effects, including:
These are not all the possible side effects of Rezdiffra. For more information, ask your healthcare provider or pharmacist.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Madrigal Pharmaceuticals, Inc. at 1-800-905-0324.
Rezdiffra is a prescribed medicine used along with diet and exercise to treat adults with nonalcoholic steatohepatitis (NASH) with moderate to advanced liver scarring (fibrosis), but not with cirrhosis of the liver.
It is not known if Rezdiffra is safe and effective in children (under 18 years old).
This indication is approved based on improvement of NASH and liver scarring (fibrosis). There are ongoing studies to confirm the clinical benefit of Rezdiffra.
Please see the full Prescribing Information, including Patient Information, for Rezdiffra.